ID

14779

Description

Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00793546

Link

https://clinicaltrials.gov/show/NCT00793546

Keywords

Versions (1)
  1. 4/27/16 4/27/16 -
Uploaded on

April 27, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Advanced Breast Cancer NCT00793546

English

Eligibility Advanced Breast Cancer NCT00793546

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
woman aged 18 years or older.
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
confirmed pathologic diagnosis of breast cancer
Description

breast cancer

Data type

boolean

Alias
UMLS CUI [1]
C0678222
locally advanced, metastatic, or locoregional recurrent breast cancer not amenable to curative treatment with surgery or radiotherapy.
Description

recurrent breast cancer

Data type

boolean

Alias
UMLS CUI [1]
C0278493
surgically sterile or postmenopausal woman
Description

surgically sterile or postmenopausal woman

Data type

boolean

Alias
UMLS CUI [1]
C0021359
UMLS CUI [2]
C0232970
documented er+ and/or pgr+ and erbb2- tumor
Description

er+ and/or pgr+ and erbb2- tumor

Data type

boolean

Alias
UMLS CUI [1]
C2938924
UMLS CUI [2]
C2367479
progression of locally advanced or metastatic disease during treatment with a nonsteroidal ai or tamoxifen, or progression during treatment with (or within 6 months of discontinuation of) an adjuvant nonsteroidal ai.
Description

advanced or metastatic disease

Data type

boolean

Alias
UMLS CUI [1]
C0027627
UMLS CUI [2]
C0039286
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior exemestane, prior bosutinib, or any other prior anti-src therapy.
Description

exemestane, bosutinib

Data type

boolean

Alias
UMLS CUI [1]
C0060116
UMLS CUI [2]
C1831731
more than 1 prior endocrine treatment for locally advanced or mbc
Description

endocrine treatment

Data type

boolean

Alias
UMLS CUI [1]
C0038900
more than 1 prior cytotoxic chemotherapy regimen in metastatic setting.
Description

cytotoxic chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0677881
bone or skin as the only site of disease.
Description

bone or skin

Data type

boolean

Alias
UMLS CUI [1]
C0391978
UMLS CUI [2]
C1123023
Back to the top of the page

Similar models

Eligibility Advanced Breast Cancer NCT00793546

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
woman aged 18 years or older.
boolean
C0001779 (UMLS CUI [1])
breast cancer
Item
confirmed pathologic diagnosis of breast cancer
boolean
C0678222 (UMLS CUI [1])
recurrent breast cancer
Item
locally advanced, metastatic, or locoregional recurrent breast cancer not amenable to curative treatment with surgery or radiotherapy.
boolean
C0278493 (UMLS CUI [1])
surgically sterile or postmenopausal woman
Item
surgically sterile or postmenopausal woman
boolean
C0021359 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
er+ and/or pgr+ and erbb2- tumor
Item
documented er+ and/or pgr+ and erbb2- tumor
boolean
C2938924 (UMLS CUI [1])
C2367479 (UMLS CUI [2])
advanced or metastatic disease
Item
progression of locally advanced or metastatic disease during treatment with a nonsteroidal ai or tamoxifen, or progression during treatment with (or within 6 months of discontinuation of) an adjuvant nonsteroidal ai.
boolean
C0027627 (UMLS CUI [1])
C0039286 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
exemestane, bosutinib
Item
prior exemestane, prior bosutinib, or any other prior anti-src therapy.
boolean
C0060116 (UMLS CUI [1])
C1831731 (UMLS CUI [2])
endocrine treatment
Item
more than 1 prior endocrine treatment for locally advanced or mbc
boolean
C0038900 (UMLS CUI [1])
cytotoxic chemotherapy
Item
more than 1 prior cytotoxic chemotherapy regimen in metastatic setting.
boolean
C0677881 (UMLS CUI [1])
bone or skin
Item
bone or skin as the only site of disease.
boolean
C0391978 (UMLS CUI [1])
C1123023 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial